We are live on
!
Find out more
CAC
Core Alternative Capital Portfolio holdings
AUM
$339M
1-Year Est. Return
18.22%
This Fund
S&P 500
This Quarter
Est. Return
+7.38%
1 Year Est. Return
+18.22%
3 Year Est. Return
+57.45%
5 Year Est. Return
+82.24%
10 Year Est. Return
–
AUM
$558M
AUM Growth
-$25.3M
(-4.3%)
Cap. Flow
-$61.3M
Cap. Flow
% of AUM
-10.98%
Top 10 Holdings %
Top 10 Hldgs %
30.28%
Holding
381
New
17
Increased
25
Reduced
294
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$447K |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$403K |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$288K |
| 4 |
Medtronic
MDT
|
+$286K |
| 5 |
TE Connectivity
TEL
|
+$281K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$4.75M |
| 2 |
Microsoft
MSFT
|
+$3M |
| 3 |
Advanced Micro Devices
AMD
|
+$2.91M |
| 4 |
Merck
MRK
|
+$2.52M |
| 5 |
Broadridge
BR
|
+$2.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.14% |
| 2 | Financials | 15.17% |
| 3 | Healthcare | 13.18% |
| 4 | Consumer Staples | 10.15% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Ball Corp
BALL
$17B
| $1.42K | ﹤0.01% |
21
-103
| -83% | -$6.26K |
|
|
WRK
277
DELISTED
WestRock Company
WRK
| $1.39K | ﹤0.01% |
+28
| New | +$1.22K |
|
278
Allstate
ALL
$66.9B
| $1.38K | ﹤0.01% |
8
-102
| -93% | -$16.1K |
|
279
Cintas
CTAS
$82.4B
| $1.37K | ﹤0.01% |
8
-88
| -92% | -$13.5K |
|
280
Aptiv
APTV
$12B
| $1.35K | ﹤0.01% |
17
-72
| -81% | -$5.81K |
|
281
DT Midstream
DTM
$14.9B
| $1.34K | ﹤0.01% |
22
-204
| -90% | -$11.4K |
|
282
Welltower
WELL
$178B
| $1.31K | ﹤0.01% |
14
-162
| -92% | -$14.7K |
|
283
Devon Energy
DVN
$51.9B
| $1.3K | ﹤0.01% |
26
-227
| -90% | -$10.1K |
|
|
BNY
284
Bank of New York Mellon
BNY
$108B
| $1.27K | ﹤0.01% |
22
-222
| -91% | -$12.2K |
|
285
FTI Consulting
FCN
$4.82B
| $1.26K | ﹤0.01% |
6
-79
| -93% | -$15.9K |
|
286
Kinder Morgan
KMI
$73.1B
| $1.23K | ﹤0.01% |
67
-676
| -91% | -$11.8K |
|
287
KKR & Co
KKR
$89.2B
| $1.21K | ﹤0.01% |
12
-149
| -93% | -$13.7K |
|
288
Incyte
INCY
$23.5B
| $1.2K | ﹤0.01% |
21
-145
| -87% | -$8.7K |
|
289
West Pharmaceutical
WST
$23.1B
| $1.19K | ﹤0.01% |
3
-19
| -86% | -$7.03K |
|
290
Cummins
CMI
$91.7B
| $1.18K | ﹤0.01% |
4
-46
| -92% | -$11.9K |
|
291
Prudential Financial
PRU
$41.7B
| $1.17K | ﹤0.01% |
10
-112
| -92% | -$12.1K |
|
292
Northern Trust
NTRS
$22.2B
| $1.16K | ﹤0.01% |
13
-76
| -85% | -$6.23K |
|
293
Oneok
OKE
$58.7B
| $1.12K | ﹤0.01% |
14
-145
| -91% | -$10.6K |
|
294
MSCI
MSCI
$40B
| $1.12K | ﹤0.01% |
2
-20
| -91% | -$11.2K |
|
295
Fidelity National Information Services
FIS
$21.5B
| $1.11K | ﹤0.01% |
15
-128
| -90% | -$8.33K |
|
296
Centene
CNC
$31.3B
| $1.1K | ﹤0.01% |
14
-184
| -93% | -$14.2K |
|
297
Ametek
AME
$55.5B
| $1.1K | ﹤0.01% |
6
-68
| -92% | -$11.7K |
|
298
SBA Communications
SBAC
$18.4B
| $1.08K | ﹤0.01% |
5
-35
| -88% | -$7.79K |
|
299
CBRE Group
CBRE
$40.8B
| $1.07K | ﹤0.01% |
11
-99
| -90% | -$8.89K |
|
300
Equifax
EFX
$20.3B
| $1.07K | ﹤0.01% |
4
-33
| -89% | -$8.4K |
|
Similar funds
PB
CWM
BAM
WCM
VCM
BCM
SCM
JCIA
Core Alternative Capital's Q1 2024 Portfolio in Review
As of Q1 2024, Core Alternative Capital held 381 positions worth $558M, down 4.3% from $583M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Core Alternative Capital withdrew a net $61.3M in Q1 2024, closing 27 positions and reducing 294 holdings. Its most notable exit was Berkshire Hathaway Class A, an estimated $543K position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Core Alternative Capital opened a new position in iShares Core S&P 500 ETF worth $470K.
- Core Alternative Capital's largest Q1 2024 buy was iShares Core S&P 500 ETF: 894 shares worth $470K.
- Core Alternative Capital added most to Alphabet (Google) Class C in Q1 2024, an estimated $403K increase.
- Core Alternative Capital's biggest Q1 2024 reduction was Eli Lilly, cutting an estimated $4.75M.
- Core Alternative Capital fully exited Berkshire Hathaway Class A in Q1 2024, selling an estimated $543K.
- Core Alternative Capital's ten largest holdings make up 30% of its $558M portfolio in Q1 2024.
- Core Alternative Capital opened 17 new positions and closed 27 in Q1 2024.
- Core Alternative Capital's portfolio value fell 4.3% quarter-over-quarter to $558M.
Based on Core Alternative Capital's 13F filing for Q1 2024, filed 15 May 2024.